(Q39971485)

16 September 2017

title

Site-specific modification of AAV vector particles with biophysical probes and targeting ligands using biotin ligase (English)

1 reference

16 September 2017

Matthew D Stachler

1

1 reference

16 September 2017

Irwin Chen

series ordinal

2

1 reference

16 September 2017

Alice Y Ting

series ordinal

3

1 reference

16 September 2017

Jeffrey S Bartlett

series ordinal

4

1 reference

16 September 2017

language of work or name

1 reference

17 June 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

16

1 reference

16 September 2017

issue

8

1 reference

16 September 2017

page(s)

1467-1473

1 reference

Fluorescent viral vectors: a new technique for the pharmacological analysis of gene therapy

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Notch1 augments intracellular trafficking of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Labeling of fusion proteins with synthetic fluorophores in live cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Methotrexate conjugates: a molecular in vivo protein tag.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

In vivo targeting of organic calcium sensors via genetically selected peptides

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Reversible site-selective labeling of membrane proteins in live cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Altering AAV tropism with mosaic viral capsids.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Site-specific labeling of cell surface proteins with biophysical probes using biotin ligase

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Antibody engineering and its applications in tumor targeting and intracellular immunization

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Recombinant antibody constructs in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Capsid modifications overcome low heterogeneous expression of heparan sulfate proteoglycan that limits AAV2-mediated gene transfer and therapeutic efficacy in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.129

7 January 2021

Identifiers

DOI

10.1038/MT.2008.129

1 reference

16 September 2017

1 reference